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ABSTRACT 
Leucorrhoea i.e. Shwetapradar is universal problem of women which is caused by increased 
stress, strain, improper diet & unhygienic conditions. Most commonly used treatment according 
to modern science is vaginal pessaries which act fast & give symptomatic relief but they have 
chances of recurrence. Ayurveda advocates healthy lifestyle including proper diet & treatment 
regime to manage such diseases & its recurrence. According to Ayurveda Ahar is the main reason 
for being healthy or diseased. Considering this, a clinical study has been planned with an aim of 
“To evaluate the role of Takra & Odan as Ahar along with Nagkeshar churna in Shwetapradar”. 
For the study, 60 patients having symptoms of Shwetapradar were selected & divided in two 
groups randomly. Trial group (Group A) was treated with Nagkeshar churna along with Takra & 
Odan as Ahar whereas control group (Group B) was treated with Nagkeshar churna alone for 21 
days with weekly follow up. After the completion of study it was observed that relief obtained in 
symptoms was faster in Group A than in Group B. Also relief obtained was much more in Group A 
than in Group B. Hence study was concluded that the formulation stimulates astringent action in 
vaginal mucosa and reduces excessive vaginal discharge & pelvic congestion. Thus dietary 
modifications play a significant role in curing Shwetapradar. 
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INTRODUCTION 
Ayurveda – literally means “science of life” is 
based on the twin principles of wholeness & balance. 
As a holistic healing tradition, Ayurveda recommends 
treating the “Whole” person - body, mind, senses, 
emotions & spirit instead of following the “One cause 
- One cure” principle & focusing on the symptoms of 
the moment. The premise is that if roots are 
nourished & watered the plant will flourish. 
According to Acharya Sushrut it is only due to diet 
the strength, immunity, clarity of complexion & sense 
organs develops & so are diseases due to irregularity 
of diet1. In Ayurveda Ahar (food), Nidra (sleep) and 
Brahmacharya (celibacy) are three pillars or tripod of 
healthy living (Swasthya)2. It is important for our 
body to be adjusted to the timely intake of good 
quality & proper food & sleeping habits3. 
Starting from the 21st century is the time of 
civilization & competitive life. In all fields women are 
competing equally with man & more efforts to 
counter this extra burden. As a result women are 
facing many physical ailments in which Leucorrhoea 
is one of the most common problems.  
Leucorrhoea, a vaginal discharge is present in 70-
80% of women which makes embarrassing to get into 
social gathering & even engage in personal life. 
Fatigue, Stomach cramps, headache, constipation, 
pain in lumbar region are the associated symptoms. 
Ignorance may lead to severe complications. The 
affected women need assurance, prevention of 
infection & some counseling. Patient get symptomatic 
relief after allopathic treatment, but it is not 
completely cured & they come with the same 
complications repeatedly. With the help of Ayurveda, 
we can give a good result in Leucorrhoea. Ayurvedic 
dietetics (Pathyahar) helps to reduce symptoms of 
Shwetapradara and also helps in prevention. As 
stated in Yog Ratnakar Takra & Odan along with 
Nagkeshar is very beneficial for the Leucorrhoea4. 
Takra & Odan are the part of Ahar and are easily 
available, digestible & affordable. Nagkeshar Churna 
is also easily available. So, to reestablished the 
importance of Ayurvedic dietetics related to 
Shwetapradara the disease is selected for the clinical 
study.  
 
Int. J. Ayur. Pharma Research, 2019;7(12):7-13 
     Available online at: http://ijapr.in  8 
AIMS & OBJECTIVES 
1. To review Ayurvedic & modern literature 
available on Shvetapradara. 
2. To review the literature available on Takra, Odan 
& Nagkeshar. 
3. To evaluate the efficacy of Takra, Odan & 
Nagkeshar as preventive aspect in Shvetapradara. 
MATERIAL AND METHOD 
Name of the centre: M.A.Podar Hospital, Mumbai. 
Type of the study: Open controlled randomized 
study. 
Ethical Aspect: The study protocol was approved by 
ethical committee. 
No. of patients: The total number of patients i.e., 60 
will be divided into 2 groups with 30 patients in each 
group based on random selection. 
Selection criteria 
Inclusion criteria 
1. Married women of age between 18 to 40 years. 
2. All the patients of vaginitis, cervicitis, IUCD, PID, 
anaemia, etc. 
3. Yonivyapda having symptoms like excessive 
Yonistrava, Yonikandu and Yonidaurghandya. 
Exclusion criteria 
1. Unmarried. 
2. Pregnant and PNC patients upto 6 months. 
3. Patients having bleeding per vagina from any 
cause. 
4. Premalignancy & malignancy of genital tract. 
5. Uterine or cervical polyp, fibroid or tumour. 
6. VDRL, HIV, HBsAg positive patients. 
Drug - Takra : 200 ml  
 Odan : 50 gm  
Nagkeshar: 5 gm 
Method of preparation 
Takra Kalpana 
According to Yogratnakar & Bhavaprakasha 
Takra is prepared by adding one part of curd to the 
1/4th of water & churned well. Butter is not separated 
from the Takra. It should be neither more 
concentrated nor diluted & should be Madhura & 
Kashaya Rasa5. 
Preparation of Odana 
First take 50gms of Shashtika & rinse it with 
clean water. Then soak the rice grains for 10 mins. 
After that add five times more water to it & then 
allow it to cook. After the rice is cooked, take out the 
Mand (rice water) from it6. 
 
 
 
Nagkeshar churna 
Nagkeshar churna is made available from 
M.A.Podar Hospital as it is Govt. supply to Podar 
hospital.  
Duration of the treatment: 21 days. 
Follow up will be maintained on every week. 
CRIETERIA FOR ASSESSMENT 
 A specially designed case record form (CRF) will be 
use to record clinical signs & symptoms, general 
symptoms, perspeculum, and laboratory findings. 
Criteria for Diagnosis 
Patients having symptoms 
1. Amount of discharge 
2. Itching 
3. Lower abdominal pain 
4. Low backache 
5. Frequency of micturation 
Gradation of Symptoms 
Amount of Discharge 
Grade 0- No discharge 
Grade 1- mild, slight discharge p/v only vulval 
moistness 
Grade 2- moderate, staining undergarments only 
Grade 3- severe, need pad 
Itching 
Grade 0- Absent 
Grade 1- mild, occasional feeling irritability 
Grade 2- moderate, excoriation, disturb routine 
but no need to take medicine 
Grade 3- severe, with excoriation of vulva & need 
to take medicine 
Lower Abdominal Pain 
Grade 0- Absent 
Grade 1- mild 
Grade 2- moderate 
Grade 3- severe 
Low backache 
Grade 0- No backache 
Grade 1- mild, backache on working & get relief 
on rest 
Grade 2- moderate, backache on rest also & get 
relieved by local application 
Grade 3- severe backache & need medication 
Urinary Frequency 
Grade 0: 3-4 times in a day 
Grade 1: 4-6 times in a day 
Grade 2: 6-8 times in a day 
Grade 3: more than 8 times in a day 
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Per speculum Examination 
Vaginitis, cervicitis & discharge will be record as 
Grade 0: nil 
Grade 1: mild 
Grade 2: moderate 
Grade 3: severe 
Gradation of PH 
Grade 0: 4-4.5 
Grade 1: 4.6-5.5 
Grade 2: 5.6-6.6 
Grade 3: 6.6 and above 
Statistical Analysis 
  To reach the final result & conclusion the 
data that has generated during the study was 
subjected to statistical analysis. Wilcox son signed 
rank sum test and Mann-Whitney Test were applied 
for evaluation of subjective data while Paired t test 
and Unpaired t test were applied for evaluation of 
objective data. Significance of the results was studied 
at 5% level of significance. 
Total Effect of Therapy 
The effect of the therapy was assessed in terms of 
totally cured, cured, markedly improved, improved 
and unchanged. The details are as follows- 
1. Cured: 75% to 100% relief, from all the signs & 
symptoms, was considered as cured. 
2. Markedly Improved: 50% to 75% relief from, the 
signs & Symptoms, was considered as markedly 
improved. 
3. Improved: 25% to 50% relief, from the signs & 
symptoms was, considered as improved. 
4. Unchanged: Less than 25% or no relief, from the 
signs & Symptoms, was considered as unchanged. 
5. LAMA: Those patients who left the treatment 
before advised duration or who did not followed the 
instruction about Ahara-Vihara were considered as 
left against medical advice (LAMA) 
Table 1: Age wise distribution 
Sr. no Age in (yrs) Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 18-29 14 46.66% 13 43.33% 27 45% 
2 30-40 16 53.33% 17 56.66% 33 55% 
Table 2: Weight wise distribution 
Sr. no Weight in (kg) Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 30-45 13 43.33% 08 26.66% 21 35% 
2 46-60 10 33.33% 14 46.66% 24 40% 
3 Above 60 07 23.33% 08 26.66% 15 25% 
Table 3: Diet wise distribution 
Sr. No Diet Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 Vegetarian 05 16.66% 04 13.33% 09 15% 
2 Mixed 25 83.33% 26 86.66% 51 85% 
Table 4: Religion wise distribution 
Sr. No Religion Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 30-45 25 83.33% 23 76.66% 48 80% 
2 46-60 02 6.66% 03 10% 05 8.33% 
3 Above 60 03 10% 04 13.33% 07 11.66% 
Table 5: Education wise distribution 
Sr. No Education Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 Uneducated 05 16.66% 06 20% 11 18.33% 
2 Upto SSC 21 70% 17 56.66% 38 63.33% 
3 SSC to Graduate 04 13.33% 07 23.33% 11 18.33% 
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Table 6: Occupation wise distribution 
Sr. No Occupation Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 Housewife 28 93.33% 27 90% 55 91.66% 
2 Employee 02 6.66% 03 10% 05 8.33% 
Table 7: Socio economic status wise distribution 
Sr. No Socioeconomic 
status 
Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 Lower economic 
class (poor) 
13 43.33% 10 33.33% 23 38.33% 
2 Middle economic 
class 
17 56.66% 18 60% 35 58.33% 
3 Higher economic 
class 
00 00 02 6.66% 02 3.33% 
Table 8: Prakruti wise distribution 
Sr. No Prakruti Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 Vatakaphaja 12 40% 15 50% 27 45% 
2 Vatapittaja 09 30% 08 26.66% 17 28.33% 
3 Kaphavataja 08 26.66% 05 16.66% 13 21.66% 
4 Kaphapittaja 01 3.33% 01 3.33% 02 3.33% 
5 Pittajavataja 00 00 00 00 00 00 
6 Pittajakaphaja 00 00 01 3.33% 01 1.66% 
Table 9: Obstetrical history wise distribution 
Sr. no Obst. History Trial group Control group Total no pts 
  No. of pts % No. of pts % 60 % 
1 Vaginal delivery 15 50% 15 50% 30 50% 
2 Recurrent 
abortion 
06 10% 09 30% 15 25% 
3 IUCD 02 6.66% 02 6.66% 04 6.66% 
4 Nulliparous 07 11.66% 04 13.33% 11 18.33% 
Statistical Analysis  
Table 10: Statistical Analysis of effects of therapy on subjective parameters in Group A By Wilcoxon 
signed rank test 
Sr. no Symptom  Mean SD SE Sum of all 
signed ranks 
No. of 
pairs 
Value 
of ‘Z’ 
P 
1 Amount of 
discharge 
 
BT 1.433 0.6789 0.1240 300 24 4.2857 <0.001  
Highly 
Significant  
AT 0.400 0.6215 0.1135 
DIFF 1.033 0.6687 0.1221 
2 Itching BT 1.433 0.6789 0.1240 300 24 4.2857 <0.001  
Highly 
Significant  
AT 0.400 0.6215 0.1135 
DIFF 1.033 0.6687 0.1221 
3 Low 
abdominal 
pain 
BT 1.867 0.5713  351 26 4.4573 <0.001  
Highly 
Significant  
AT 0.500 0.6823  
DIFF 1.367 0.7184  
4 Low BT 1.267 0.7397  259 24 3.7 <0.001  
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Backache AT 0.3333 0.6065  Highly 
Significant  DIFF 0.9333 0.8683  
5 Urinary 
frequency 
BT 0.9667 0.7649 0.1396 171 18 3.7235 <0.001  
Highly 
Significant  
AT 0.2667 0.5822 0.1065 
DIFF 0.700 0.6513 0.1189 
6 Pap smear BT 1.900 0.8449  351 26 4.4573 <0.001  
Highly 
Significant  
AT 0.8667 0.7761  
DIFF 1.033 0.5561  
7 PH BT 0.8333 0.4611  253 22 4.1071 <0.001  
Highly 
Significant  
AT 0.1 0.3051  
DIFF 0.733 0.4498  
Table 11: Statistical Analysis of effects of therapy on subjective parameters in Group B By Wilcoxon 
signed rank test 
Sr. No Symptom  Mean SD SE Sum of all 
signed ranks 
No. of 
pairs 
Value 
of ‘Z’ 
P 
1 Amount of 
discharge 
BT 2.0 0.5164  275 25 3.699 <0.001  
Highly  
Significant  
AT 1.710 3.635  
DIFF 0.2903 4.002  
2 Itching BT 1.700 0.5350  136 16 3.5162 <0.001  
Highly  
Significant  
AT 1.033 0.6687  
DIFF 0.667 0.7112  
3 Low 
abdominal 
pain 
BT 1.710 0.8638  228 24 3.2571 <0.001  
Highly  
Significant  
AT 0.8667 0.6288  
DIFF 0.9 1.155  
4 Low 
Backache 
BT 1.4 0.7240  96 15 2.7272 <0.001  
Highly  
Significant  
AT 0.8 0.7611  
DIFF 0.6 0.9322  
5 Urinary 
frequency 
BT 0.8333 0.6989  66 11 2.9340 <0.001  
Highly  
Significant  
AT 0.4333 0.5040  
DIFF 0.4 0.5632  
6 Pap smear BT 1.933 0.7849  190 19 3.8230 <0.001  
Highly  
Significant  
AT 1.200 0.9965  
DIFF 0.733 0.6397  
7 PH BT 1.133 0.5713  105 14 3.2967 <0.001  
Highly  
Significant  
AT 0.6667 0.5467  
DIFF 0.4667 0.5074  
Table 12: Comparison of Results of two Groups by Mann Whitney U Test 
Sr. No Symptom ∑R1 ∑R2 U1 U2 SD Z P 
1 Amount of discharge 1023 807 342 558 67.63 1.59 <0.05 significant 
2 Itching 1043 787.5 322 578 67.63 1.89 <0.05 significant 
3 Lower abdominal pain 1064.0 766 301 599 67.63 2.2 <0.001 very significant 
4 Low backache 1025.5 804.5 339.5 560.5 67.63 1.633 <0.05 significant 
5 Urinary frequency 1027.5 802.5 337.5 562.5 67.63 1.633 <0.05 significant 
6 Pap smear 1016.0 814.00 349.0 551.0 67.63 1.49 <0.05 significant 
7 Ph 1035 795 330 570 67.63 1.774 <0.05 significant 
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DISCUSSION 
 The study entitled, “Role of Takra-Odan as 
Ahar along with Nagkeshar Churna In Prevention & 
Control of Shwetapradara, aimed at evaluating the 
efficacy of diet modification along with internal 
medications in the patients of Shwetapradara. 
Patients were selected on OPD basis and divided 
randomly in two groups.  
The findings of clinical study are discussed critically 
as under. 
 Discussion on demographic analysis 
 Discussion on clinical efficacy of therapy 
 Probable mechanism of action of drug 
The demographic analysis of 60 patients is as 
follows 
Age 
55% of patients belonged to age group 30-40 
years. This shows that the Shwetapradara is more 
common in women of reproductive age group. 
Weight 
40% of patients in the study had weight 
ranging between 46-60 kg. 
Diet 
85% of patients ate non vegetarian diet. This 
shows that non veg diet plays significant role in 
causing Shwetapradara. Non vegetarian diet causes 
Agnimandya and Strotavrodha resulting into vitiation 
of Doshas. 
Prakruti 
It was observed that Kapha and Vata doshas 
play an important role in etio pathogenesis of 
Shwetapradara. Vatakaphaja 45%, Vaatapittaja 
28.33% Prakruti followed by Kaphavataja 21.66% 
Prakruti.  
Symptoms wise distribution of patients 
Next to discharge, 93.33% of patients had 
itching whereas only 45% of patients had increased 
frequency of urination. This might be because of 
irritant nature of the discharge. 
Analysis on the clinical efficacy of the therapy 
suggested the following 
 The % of relief observed in both groups & was 
further put to statistical analysis. 
 In both groups, by Wilcoxon signed rank test, 
significant results were obtained at the end of 
clinical trial. 
 By Mann Whitney test, comparison of both the 
groups was done.  
The results of this test were significant in all 
symptoms 
 The results obtained in both the groups are 
statistically significant. 
 Thus Nagkesar can be a drug of choice in 
treating leucorrhoea. 
 The results of Group A are significant than the 
Group B, hence dietary modifications along with 
the drug enhances the effect of the drug thereby 
play an important role in curing the 
Leucorrhoea. 
Probable mechanism of action of drug 
Takram laghu kashayaamlam deepanam 
kaphavaatajit ||  
By virtue of its properties, it exerts Grahi effect on the 
discharge, thereby reducing the discharge. Besides it 
causes Agnideepan, resulting into mitigation of 
aggravated Apaaan vaayu and Kapha dosha. It also 
causes the Pachana of Kleda produced by vitiated 
Kaphadosha7. 
Rasa - Kashaya, Madhura 
Guna - Laghu, Ruksha, Grahi, Vikasi, Agnideepaka 
Virya - Ushna 
Vipaka - Madhura 
 Being Vikasi it might be channelizing the 
Avruddha strotas, resulting into Agni deepana, 
mitigation of vitiated Apaan vaayu and Pachan of 
Vikruta kaphha.  
Being Kashaya and Grahi it might be reducing the 
vaginal discharge. 
It might be altering the vaginal mucosal ph by 
alteration of gut flora in vaginitis. 
Modern view: 
 The immunostimulatory activity of 
buttermilk is probably due to presence of lactic acid 
bacteria as well as non bacterial components of 
buttermilk. 
Buttermilk consumption increases antibody 
production, cytokines production, phagocyte activity, 
natural killer cell activity and T cell function. 
Odan 
Odan is Deepan & Paachan in properties which help 
to pacify excessive Vatakapha dosha in Leucorrhea8.  
Nagkesara: It has following properties9: 
Rasa: Kashaya (astringent), Tikta (bitter) 
Guna: Laghu (light), Ruksha (dry) 
Virya: Ushna (hot) 
Vipaka: Katu (pungent) 
Doshakarma: Kapha-pittashamak  
CONCLUSION 
Following conclusions can be made from the study: 
 Significant results are obtained in case of all the 
parameters in both Groups concluding that 
Nagkesar is a drug of choice in Leucorrhoea. 
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 As compared to group B, results of group A, in 
which Nagkesar was given along with Takra and 
odan, are significant. 
 Thus Takra and Odan enhances the effect of 
Nagkesar churna in leucorrhoea and hence this 
can be concluded that dietary modifications play a 
significant role in the treatment of leucorrhoea. 
 The formulation stimulates astringent action in 
vaginal mucosa and reduces excessive vaginal 
discharge in the vagina tract. 
 Takra probably restores vaginal pH thereby 
enhancing the effect of Nagkesar churna in Shweta 
pradar. 
 Takra, hence acts as a probiotic in the treatment of 
leucorrhoea. 
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